High-Intensity Interval Training on Pre-Hypertensive Subjects
- Conditions
- HypertensionMetabolism Disorder
- Interventions
- Behavioral: High Intensity Interval TrainingBehavioral: Control group
- Registration Number
- NCT03000140
- Lead Sponsor
- Universidad Santo Tomas
- Brief Summary
Despite exercise training decrease blood pressure in 'average' terms, there is a wide interindividual variability after exercise training, being yet unknown what mode of exercise (e.g. endurance, strength, concurrent, or high intensity interval training) produce more/less non-responder (NR) prevalence (i.e., percentage of subjects who experienced a non-change/worsened response after training in some outcome).
- Detailed Description
Despite exercise training decrease blood pressure in 'average' terms, there is a wide interindividual variability after exercise training, being yet unknown what mode of exercise (e.g. endurance, strength, concurrent, or high intensity interval training) produce more/less non-responder (NR) prevalence (i.e., percentage of subjects who experienced a non-change/worsened response after training in some outcome).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 142
- Written informed consent;
- Interested in improving health and fitness;
- Systolic blood pressure > 120 mmHg and < 140 mmHg, and/or DBP ≥ 80 and < 90 mmHg according with standard classification;
- No drug therapy during the previous 3 months;
- Body mass index (BMI) 25 and 35 kg/m2); (c) physically inactive (according to the International Physical Activity Questionnaire previously validated in Chilean population)
- Normal /mild altered lipid profile (total cholesterol [TC] ~200 and ≤250 mg/dL, low-density lipids [LDL-C] ~140 mg/dL and ≤200 mg/dL, high-density lipids [HDL-C] ≥20 and ~40 mg/dL, triglycerides ~150 and ≤250 mg/dL) according with standard classification.
- Cardiovascular contraindications to exercise histories of stroke;
- Asthma and chronic obstructive pulmonary disease;
- Musculoskeletal disorder such as low back pain;
- Smokers in the last 3 months were not included in the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description High Intensity Interval Training High Intensity Interval Training Cycling on cycle ergometers (OXFORDTM, model BE2601, OXOFORD Inc, Santiago, Chile) for 1 min at a subjective intensity of 8-10 points of the modified Borg scale of 1-10 points, and interspersed by inactive (without movement over the bicycle) of 2 minutes as recovery period. Control group Control group Pre-hypertensive group was compared with healthy groups in the 2 manin variables systolic/diastolic blood pressure, as well as in other co-variables in pre-post changes. Thus, after the training intervention, and following the R and NR classification, we will compare the NR prevalence between both Pre-hypertensive and Healthy group.
- Primary Outcome Measures
Name Time Method Change from Baseline in systolic blood pressure and diastolic blood pressure Baseline and 16 weeks immediately after the interventions ends After this, we calculated the delta changes in both variables and classified to all subjects in responders (R) and non-responders (NR) to decrease systolic or diastolic blood pressure.
- Secondary Outcome Measures
Name Time Method Change from Baseline in waist circumference Baseline and 16 weeks immediately after the interventions ends Change from Baseline in fat mass Baseline and 16 weeks immediately after the interventions ends Change from Baseline in body mass index Baseline and 16 weeks immediately after the interventions ends BMI will be calculated as the body weight in kilograms divided by the square of the height in meters.
Change from Baseline in body mass Baseline and 16 weeks immediately after the interventions ends Change from Baseline in one maximum repetition strength test of leg-extension exercise Baseline and 16 weeks immediately after the interventions ends Change from Baseline in heart rate at rest Baseline and 16 weeks immediately after the interventions ends Baseline and 16 weeks immediately after the interventions ends
Change from Baseline in fasting glucose Baseline and 16 weeks immediately after the interventions ends Change from Baseline in lipids Baseline and 16 weeks immediately after the interventions ends Lipid profile (low-density cholesterol, total cholesterol, high-density cholesterol and triglycerides)
Trial Locations
- Locations (1)
Cristian Alvarez
🇨🇱Osorno, Chile